These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24982037)

  • 21. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.
    Payne D; Tomasz A
    Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496
    [No Abstract]   [Full Text] [Related]  

  • 22. The Role of Antibiotic Stewardship and Telemedicine in the Management of Multidrug-Resistant Infections.
    File TM; Jump RLP; Goff DA
    Infect Dis Clin North Am; 2020 Dec; 34(4):903-920. PubMed ID: 33131574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An emerging multidrug-resistant bacteria.
    Johnstone J; Patel SN;
    CMAJ; 2017 Sep; 189(35):E1115. PubMed ID: 28874433
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibiotic resistance.
    Frieri M; Kumar K; Boutin A
    J Infect Public Health; 2017; 10(4):369-378. PubMed ID: 27616769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What's new on the antimicrobial horizon?
    Song JH
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microbiological approach to antibiotic therapy against multidrug-resistant bacteria].
    Kusachi S
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):527-9. PubMed ID: 12884778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective digestive tract decontamination--will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic?
    Bonten MJ
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S70-4. PubMed ID: 16894518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fosfomycin--its significance for treatment of diseases due to multidrug-resistant bacteria].
    Stock I
    Med Monatsschr Pharm; 2015 Jan; 38(1):4-11. PubMed ID: 26349119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial infections epidemiology and factors associated with multidrug resistance in the northern region of Ghana.
    Gnimatin JP; Weyori EW; Agossou SM; Adokiya MN
    Sci Rep; 2022 Dec; 12(1):22069. PubMed ID: 36543904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Origin and proliferation of multiple-drug resistance in bacterial pathogens.
    Chang HH; Cohen T; Grad YH; Hanage WP; O'Brien TF; Lipsitch M
    Microbiol Mol Biol Rev; 2015 Mar; 79(1):101-16. PubMed ID: 25652543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent bacterial infections and persister cells.
    Fisher RA; Gollan B; Helaine S
    Nat Rev Microbiol; 2017 Aug; 15(8):453-464. PubMed ID: 28529326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
    Fernández J; Prado V; Trebicka J; Amoros A; Gustot T; Wiest R; Deulofeu C; Garcia E; Acevedo J; Fuhrmann V; Durand F; Sánchez C; Papp M; Caraceni P; Vargas V; Bañares R; Piano S; Janicko M; Albillos A; Alessandria C; Soriano G; Welzel TM; Laleman W; Gerbes A; De Gottardi A; Merli M; Coenraad M; Saliba F; Pavesi M; Jalan R; Ginès P; Angeli P; Arroyo V;
    J Hepatol; 2019 Mar; 70(3):398-411. PubMed ID: 30391380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial drug development: challenges, recent developments, and future considerations.
    Nambiar S; Laessig K; Toerner J; Farley J; Cox E
    Clin Pharmacol Ther; 2014 Aug; 96(2):147-9. PubMed ID: 25056394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selecting empiric antibiotic therapy in an era of multi-drug resistance--is the cupboard really bare? Introduction.
    Collatz E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():1. PubMed ID: 19040460
    [No Abstract]   [Full Text] [Related]  

  • 36. New β-lactam antibiotics and β-lactamase inhibitors.
    Bush K; Macielag MJ
    Expert Opin Ther Pat; 2010 Oct; 20(10):1277-93. PubMed ID: 20839927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New antibiotic agents in the pipeline and how they can help overcome microbial resistance.
    Gould IM; Bal AM
    Virulence; 2013 Feb; 4(2):185-91. PubMed ID: 23302792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
    Soo VW; Kwan BW; Quezada H; Castillo-Juárez I; Pérez-Eretza B; García-Contreras SJ; Martínez-Vázquez M; Wood TK; García-Contreras R
    Curr Top Med Chem; 2017; 17(10):1157-1176. PubMed ID: 27697046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fighting antibiotic resistance.
    Goldhaber M
    Science; 1994 Dec; 266(5190):1462. PubMed ID: 7985006
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibiotic resistance as a major public health concern: epidemiology and economic impact.
    Ciorba V; Odone A; Veronesi L; Pasquarella C; Signorelli C
    Ann Ig; 2015; 27(3):562-79. PubMed ID: 26152543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.